Skip to main content

Table 1 Characteristics of the study groups

From: Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study

Patient Characteristics SVR (n = 26) REL (n = 10) NR (n = 32) Total (n = 68)
Median Age 54.00 56.00 56.00 55.00
Median BMI 25.96 27.15 24.58 25.49
Male (%) 62 40 56 56
  1. REL, Relapsing; NR, Non-Responder; SVR, Sustained Virological Response; BMI, Body Mass Index.
  2. No statistically significant differences were observed between the SVR, REL and NR groups (p > 0.4, G-test and Chi-square test).